Abbott Laboratories (ABT) News Today $118.77 -0.18 (-0.15%) (As of 11/29/2024 05:27 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period B&L Asset Management LLC Buys Shares of 7,527 Abbott Laboratories (NYSE:ABT)B&L Asset Management LLC purchased a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 7,527 shares of the healthcare product maker's stock, valued at approxiDecember 1 at 7:55 AM | marketbeat.comErste Asset Management GmbH Makes New $34.05 Million Investment in Abbott Laboratories (NYSE:ABT)Erste Asset Management GmbH acquired a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 302,174 shares of the healthcare product maker's stock,December 1 at 7:44 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) is Bellevue Group AG's 9th Largest PositionBellevue Group AG grew its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 8.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,743,938 shares of the healthcare product maker's stock aftDecember 1 at 7:02 AM | marketbeat.comCaisse DE Depot ET Placement DU Quebec Increases Stock Holdings in Abbott Laboratories (NYSE:ABT)Caisse DE Depot ET Placement DU Quebec boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 21.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 693,148 shares of the healthcare product maker's stock after acquiring an additionDecember 1 at 6:02 AM | marketbeat.comPDT Partners LLC Sells 8,500 Shares of Abbott Laboratories (NYSE:ABT)PDT Partners LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 35.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,200 shares of the healthcare product maker's stock after selling 8,5December 1 at 5:46 AM | marketbeat.comFred Alger Management LLC Acquires Shares of 43,301 Abbott Laboratories (NYSE:ABT)Fred Alger Management LLC purchased a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 43,301 shares of the healthcare product maker's stock, valued atDecember 1 at 5:45 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Short Interest Down 14.4% in NovemberDecember 1 at 1:11 AM | americanbankingnews.comShort Interest in Abbott Laboratories (NYSE:ABT) Declines By 14.4%Abbott Laboratories (NYSE:ABT - Get Free Report) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 12,050,000 shares, a decline of 14.4% from the October 31st total of 14,070,000 shares. Based on an average trading volume of 5,010,000 shares, the short-interest ratio is currently 2.4 days. Approximately 0.7% of the company's stock are sold short.December 1 at 1:10 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Captrust Financial AdvisorsCaptrust Financial Advisors decreased its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 15.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 377,557 shares of the healthcare product maker's stock afNovember 30 at 6:38 AM | marketbeat.comRockefeller Capital Management L.P. Decreases Stake in Abbott Laboratories (NYSE:ABT)Rockefeller Capital Management L.P. cut its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 665,257 shares of the healthcNovember 30 at 6:20 AM | marketbeat.comQuantbot Technologies LP Sells 141,543 Shares of Abbott Laboratories (NYSE:ABT)Quantbot Technologies LP lowered its position in Abbott Laboratories (NYSE:ABT - Free Report) by 90.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 15,659 shares of the healthcare product maker's stock after sellNovember 30 at 4:30 AM | marketbeat.comAtlantic Union Bankshares Corp Sells 4,950 Shares of Abbott Laboratories (NYSE:ABT)Atlantic Union Bankshares Corp cut its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 4.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 95,159 shares of the healthcare product makeNovember 29 at 8:19 AM | marketbeat.comMartingale Asset Management L P Sells 52,620 Shares of Abbott Laboratories (NYSE:ABT)Martingale Asset Management L P lowered its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 15.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 291,419 shares of the healthcare product maker's stock aNovember 29 at 7:23 AM | marketbeat.comHantz Financial Services Inc. Has $33.26 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)Hantz Financial Services Inc. lowered its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 2.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 291,753 shares of the healthcare product maker's stock aNovember 29 at 6:40 AM | marketbeat.comNorthwest & Ethical Investments L.P. Acquires 12,842 Shares of Abbott Laboratories (NYSE:ABT)Northwest & Ethical Investments L.P. raised its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 22.1% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 70,919 shares of the healthcare product maker's stock afterNovember 29 at 6:40 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Stock Holdings Lessened by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 5.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor ownedNovember 28 at 9:10 AM | marketbeat.comPublic Sector Pension Investment Board Reduces Stock Position in Abbott Laboratories (NYSE:ABT)Public Sector Pension Investment Board reduced its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 41.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 375,779 shares of the healthcare prodNovember 28 at 8:48 AM | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Has $80.97 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 710,240 shares of the healthcare productNovember 28 at 8:21 AM | marketbeat.comBBR Partners LLC Acquires 10,114 Shares of Abbott Laboratories (NYSE:ABT)BBR Partners LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 20.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 60,043 shares of the healthcare product maker's stock after buying an additional 10,114 shareNovember 28 at 7:54 AM | marketbeat.comCreativeOne Wealth LLC Increases Stake in Abbott Laboratories (NYSE:ABT)CreativeOne Wealth LLC lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 30.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 21,756 shares of the healthcare product maker's stock after purchasing anNovember 28 at 7:16 AM | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Purchases 57,049 Shares of Abbott Laboratories (NYSE:ABT)Healthcare of Ontario Pension Plan Trust Fund grew its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 14.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 443,049 shares of the healthcare product makerNovember 28 at 7:07 AM | marketbeat.comFmr LLC Sells 598,841 Shares of Abbott Laboratories (NYSE:ABT)Fmr LLC decreased its position in Abbott Laboratories (NYSE:ABT - Free Report) by 6.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,282,289 shares of the healthcare product maker's sNovember 28 at 5:47 AM | marketbeat.comLoomis Sayles & Co. L P Has $11.30 Million Position in Abbott Laboratories (NYSE:ABT)Loomis Sayles & Co. L P grew its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 47.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 99,116 shares of the healthcare product maker's stock after purchasiNovember 28 at 4:55 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Receives $130.07 Average Price Target from BrokeragesNovember 28 at 2:25 AM | americanbankingnews.comAbbott Laboratories (NYSE:ABT) Shares Sold by BNP ParibasBNP Paribas trimmed its position in Abbott Laboratories (NYSE:ABT - Free Report) by 22.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 22,881 shares of the healthcare product maker's stock after selling 6,784November 27, 2024 | marketbeat.comGlenmede Trust Co. NA Has $172.94 Million Holdings in Abbott Laboratories (NYSE:ABT)Glenmede Trust Co. NA decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,516,845 shares of the healthcare product maker's stock afterNovember 27, 2024 | marketbeat.comBridgewater Associates LP Has $80.68 Million Holdings in Abbott Laboratories (NYSE:ABT)Bridgewater Associates LP decreased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 57.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 707,615 shares of the healthcare product maker's stocNovember 27, 2024 | marketbeat.comTransamerica Financial Advisors Inc. Buys Shares of 6,302 Abbott Laboratories (NYSE:ABT)Transamerica Financial Advisors Inc. purchased a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 6,302 shares of the healthcare product makerNovember 27, 2024 | marketbeat.comUnlocking Intrinsic Value: Analysis of Abbott LaboratoriesNovember 27, 2024 | gurufocus.comJudge denies Abbott request for retrial, lower damages in $500M baby formula caseNovember 26, 2024 | msn.comStrategic Initiatives and Innovations Drive Buy Rating for Abbott LaboratoriesNovember 26, 2024 | markets.businessinsider.comAbbott Laboratories (NYSE:ABT) Holdings Raised by Prospector Partners LLCProspector Partners LLC grew its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 20.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 215,975 shares of the healthcare product maker's stock after buying an additional 36,780 shares during the quarter. AbNovember 26, 2024 | marketbeat.comD.A. Davidson & CO. Lowers Stock Holdings in Abbott Laboratories (NYSE:ABT)D.A. Davidson & CO. trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 155,257 shares of the healthcare product maker's stock after selling 4,80November 26, 2024 | marketbeat.comDai ichi Life Insurance Company Ltd Sells 10,563 Shares of Abbott Laboratories (NYSE:ABT)Dai ichi Life Insurance Company Ltd decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 12.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 72,110 shares of the healthcarNovember 26, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Sells 511,630 Shares of Abbott Laboratories (NYSE:ABT)The Manufacturers Life Insurance Company trimmed its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 11.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,143,082 shares of theNovember 26, 2024 | marketbeat.comBrown Brothers Harriman & Co. Sells 37,055 Shares of Abbott Laboratories (NYSE:ABT)Brown Brothers Harriman & Co. lessened its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.6% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,347,313 shares of the healthcare product maker's stock after selling 37November 25, 2024 | marketbeat.comDynamic Technology Lab Private Ltd Buys 12,522 Shares of Abbott Laboratories (NYSE:ABT)Dynamic Technology Lab Private Ltd increased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 146.1% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,095 shares of the healthcare product maker's sNovember 25, 2024 | marketbeat.comFisher Asset Management LLC Boosts Stake in Abbott Laboratories (NYSE:ABT)Fisher Asset Management LLC lifted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 5.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,102,204 shares of the healthcare product maker's stock after acquirNovember 25, 2024 | marketbeat.comAbbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic StenosisNovember 25, 2024 | prnewswire.comAbbott Laboratories (NYSE:ABT) Shares Sold by Jennison Associates LLCJennison Associates LLC decreased its position in Abbott Laboratories (NYSE:ABT - Free Report) by 69.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,346 shares of the healthcare prodNovember 25, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Receives Average Rating of "Moderate Buy" from AnalystsAbbott Laboratories (NYSE:ABT - Get Free Report) has earned a consensus rating of "Moderate Buy" from the sixteen research firms that are covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation toNovember 25, 2024 | marketbeat.comAbbott Laboratories: Investors Should Wait For A PullbackNovember 25, 2024 | seekingalpha.comAbbott Laboratories: Investors Should Wait For A PullbackNovember 25, 2024 | seekingalpha.comAbbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the companyNovember 24, 2024 | finance.yahoo.comDaiwa Securities Group Inc. Buys 23,834 Shares of Abbott Laboratories (NYSE:ABT)Daiwa Securities Group Inc. increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 12.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 219,229 shares of the healthcare product maker's stock after purchasingNovember 24, 2024 | marketbeat.comSummit Trail Advisors LLC Buys 7,804 Shares of Abbott Laboratories (NYSE:ABT)Summit Trail Advisors LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 38.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 28,035 shares of the healthcare product maker's stock after buying an additional 7,804 shares durNovember 24, 2024 | marketbeat.comCapital Investment Counsel LLC Trims Stake in Abbott Laboratories (NYSE:ABT)Capital Investment Counsel LLC cut its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 74.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,403 shares of the healthcare product maker's stock after selling 15,November 24, 2024 | marketbeat.comIntech Investment Management LLC Has $2.70 Million Stock Position in Abbott Laboratories (NYSE:ABT)Intech Investment Management LLC cut its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 33.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 23,662 shares of the healthcare product maker's stock afteNovember 24, 2024 | marketbeat.com20,597 Shares in Abbott Laboratories (NYSE:ABT) Purchased by Nwam LLCNwam LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 20,597 shares of the healthcare product maker's stock, valued at approximNovember 23, 2024 | marketbeat.comMeridian Wealth Management LLC Takes $2.03 Million Position in Abbott Laboratories (NYSE:ABT)Meridian Wealth Management LLC bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 17,806 shares of the healthcare product makeNovember 23, 2024 | marketbeat.com Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address ***TODAY ONLY*** Nvidia’s Next AI Play (Ad)Thanks to a specific AI Blueprint … A small handful of companies have already soared as much as 562%, 3,247% and even 6,583%. Now, with a massive recent $1 trillion pivot to data centers, six NEW stocks could be next in line to follow this pattern. Today only, the 2025 AI Blueprint has been revealed … ABT Media Mentions By Week ABT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼1.220.87▲Average Medical News Sentiment ABT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼4719▲ABT Articles Average Week Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ISRG News SYK News BSX News MDT News BDX News EW News RMD News IDXX News DXCM News STE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABT Stock Alerts